PIK3CA and metastatic neoplasm: We identified a G13C mutation in KRAS, a R130Q mutation in PTEN and a mutation in ARID1A. Interestingly, an R93Q mutation in PIK3CA was only detected in the metastatic tumor and the cell line but not in the primary tumor.